These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27054142)

  • 21. [The new ESC Guidelines for acute and chronic heart failure 2016].
    Oeing CU; Tschöpe C; Pieske B
    Herz; 2016 Dec; 41(8):655-663. PubMed ID: 27858115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2016 ESC and ACC/AHA/HFSA heart failure guideline update - what is new and why is it important?
    Jessup M; Marwick TH; Ponikowski P; Voors AA; Yancy CW
    Nat Rev Cardiol; 2016 Sep; 13(10):623-8. PubMed ID: 27625120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society.
    Kasprzak JD; Gorczyca-Głowacka I; Sobczak-Kaleta M; Barylski M; Drożdż J; Filipiak KJ; Kapłon-Cieślicka A; Lelonek M; Mamcarz A; Ochijewicz D; Ryś-Czaporowska A; Starzyk K; Szymański FM; Wełnicki M; Wożakowska-Kapłon B
    Kardiol Pol; 2023; 81(5):537-556. PubMed ID: 37179465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention.
    Abovich A; Matasic DS; Cardoso R; Ndumele CE; Blumenthal RS; Blankstein R; Gulati M
    Am J Prev Cardiol; 2023 Sep; 15():100527. PubMed ID: 37637197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines.
    MacDonald BJ; Virani SA; Zieroth S; Turgeon R
    CJC Open; 2023 Aug; 5(8):629-640. PubMed ID: 37720183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
    Taylor AL; Ziesche S; Yancy CW; Carson P; Ferdinand K; Taylor M; Adams K; Olukotun AY; Ofili E; Tam SW; Sabolinski ML; Worcel M; Cohn JN;
    Circulation; 2007 Apr; 115(13):1747-53. PubMed ID: 17372175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
    Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
    J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure per the 2017 ACC/AHA and 2018 ESC/ESH guidelines and heart failure risk: the Suita Study.
    Arafa A; Kokubo Y; Teramoto M; Kashima R; Shimamoto K; Nakao YM; Matsuo M; Yoshihara F; Izumi C
    Hypertens Res; 2023 Mar; 46(3):575-582. PubMed ID: 36609496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy implications of revised chronic heart failure guidelines.
    Crouch MA
    Consult Pharm; 2006 Jul; 21(7):576-82. PubMed ID: 16934010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to the letter regarding the article 'Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines'.
    Bayes-Genis A; Aimo A
    Eur J Heart Fail; 2024 Feb; 26(2):525-526. PubMed ID: 38229500
    [No Abstract]   [Full Text] [Related]  

  • 32. Inclusion of Performance Parameters and Patient Context in the Clinical Practice Guidelines for Heart Failure.
    Goyal P; Unlu O; Kennel PJ; Schumacher RC; Gilstrap LG; Krishnaswami A; Allen LA; Maurer MS; Rich MW; Makam A
    J Card Fail; 2021 Feb; 27(2):190-197. PubMed ID: 33065263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter regarding the article 'Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines'.
    Amini L; Kazmi S; Patel MJ
    Eur J Heart Fail; 2024 Feb; 26(2):525. PubMed ID: 38152046
    [No Abstract]   [Full Text] [Related]  

  • 34. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America.
    Jessup M; Albert NM; Lanfear DE; Lindenfeld J; Massie BM; Walsh MN; Zucker MJ
    Circ Heart Fail; 2011 May; 4(3):378-87. PubMed ID: 21464151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary.
    Heidenreich PA; Bozkurt B; Aguilar D; Allen LA; Byun JJ; Colvin MM; Deswal A; Drazner MH; Dunlay SM; Evers LR; Fang JC; Fedson SE; Fonarow GC; Hayek SS; Hernandez AF; Khazanie P; Kittleson MM; Lee CS; Link MS; Milano CA; Nnacheta LC; Sandhu AT; Stevenson LW; Vardeny O; Vest AR; Yancy CW;
    J Card Fail; 2022 May; 28(5):810-830. PubMed ID: 35378259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy.
    Stabile G; Pepi P; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Rapacciuolo A; Arena G; Marini M; Pieragnoli P; Badolati S; Savarese G; Maglia G; Iuliano A; Botto GL; Malacrida M; Bertaglia E
    Heart Rhythm; 2018 Nov; 15(11):1675-1682. PubMed ID: 29665405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
    Seferovic PM; Ponikowski P; Anker SD; Bauersachs J; Chioncel O; Cleland JGF; de Boer RA; Drexel H; Ben Gal T; Hill L; Jaarsma T; Jankowska EA; Anker MS; Lainscak M; Lewis BS; McDonagh T; Metra M; Milicic D; Mullens W; Piepoli MF; Rosano G; Ruschitzka F; Volterrani M; Voors AA; Filippatos G; Coats AJS
    Eur J Heart Fail; 2019 Oct; 21(10):1169-1186. PubMed ID: 31129923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current guidelines for treatment of heart failure: 2006 update.
    Uddin N; Patterson JH
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):12S-17S. PubMed ID: 17381370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into implementation of sacubitril/valsartan into clinical practice.
    Martens P; Beliën H; Dupont M; Mullens W
    ESC Heart Fail; 2018 Jun; 5(3):275-283. PubMed ID: 29464879
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.